Bank of America Securities analyst Allen Lutz has maintained their neutral stance on XRAY stock, giving a Hold rating yesterday.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Allen Lutz has given his Hold rating due to a combination of factors, including the recent leadership changes at DENTSPLY SIRONA. The appointment of a new CEO and CFO brings a fresh perspective, which could potentially aid in the company’s turnaround efforts. However, the transition also introduces uncertainty in the near term, affecting the visibility of the company’s strategic direction.
Despite these challenges, DENTSPLY SIRONA has a strong product portfolio in digital and endodontic/restorative care, which offers good margins. The company has faced strategic missteps and market weaknesses over the past five years, which have hindered growth in key areas. While there is potential for improvement through strategic initiatives like unlocking value in Wellspect and reinvesting in innovation, these efforts are expected to take several years to materialize. As a result, Allen Lutz maintains a Neutral rating, awaiting further clarity in the upcoming earnings call.